BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34688419)

  • 1. Evaluation and Management of Elevated Parathyroid Hormone Levels in Normocalcemic Patients.
    Cusano NE
    Med Clin North Am; 2021 Nov; 105(6):1135-1150. PubMed ID: 34688419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normocalcemic primary hyperparathyroidism.
    Cusano NE; Silverberg SJ; Bilezikian JP
    J Clin Densitom; 2013; 16(1):33-9. PubMed ID: 23374739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normocalcemic primary hyperparathyroidism.
    Bilezikian JP; Silverberg SJ
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):106-9. PubMed ID: 20485897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of normocalcemic primary hyperparathyroidism.
    Cusano NE; Cipriani C; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):837-845. PubMed ID: 30665550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normocalcemic primary hyperparathyroidism.
    Cusano NE; Cetani F
    Arch Endocrinol Metab; 2022 Nov; 66(5):666-677. PubMed ID: 36382756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Normocalcemic primary hyperparathyroidism: a growing problem].
    Martínez Díaz-Guerra G; Guadalix Iglesias S; Hawkins Carranza F
    Med Clin (Barc); 2013 Aug; 141(3):125-9. PubMed ID: 23199831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism.
    Silva BC; Cusano NE; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations.
    Cusano NE; Maalouf NM; Wang PY; Zhang C; Cremers SC; Haney EM; Bauer DC; Orwoll ES; Bilezikian JP
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2734-41. PubMed ID: 23690312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
    Majid H; Khan AH; Riaz M; Karimi H; Talati J
    Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to manage an isolated elevated PTH?
    Souberbielle JC; Cavalier E; Cormier C
    Ann Endocrinol (Paris); 2015 May; 76(2):134-41. PubMed ID: 25882890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism.
    Baugh KA; McCoy KL; Leung JH; Carty SE; Ramonell KM; Yip L
    Surgery; 2024 Jan; 175(1):166-171. PubMed ID: 37981554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].
    Hermann M
    Chirurg; 2010 May; 81(5):447-53. PubMed ID: 19468699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
    Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
    Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HYPERPARATHYROIDISM AND PARATHYROID LESIONS IN THE ChNPP ACCIDENT SURVIVORS].
    Kaminskyi OV; Kopylova OV; Afanasyev DE; Loganovsky KM; Talko VV; Muraveva IM; Chikalova IG; Tepla OV; Kiseliova IO; Bryliova NV; Gryschenko KO; Tsvet LO; Pleskach OY
    Probl Radiac Med Radiobiol; 2019 Dec; 24():380-394. PubMed ID: 31841481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatic and asymptomatic primary hyperparathyroidism in outpatient care - current issues].
    Šiprová H; Souček M; Fryšák Z; Šipr K
    Vnitr Lek; 2016; 62(10):775-780. PubMed ID: 27900863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity.
    Shlapack MA; Rizvi AA; Lopez FA
    Am J Med Sci; 2012 Feb; 343(2):163-166. PubMed ID: 22173046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperparathyroidism.
    Muñoz-Torres M; García-Martín A
    Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical spectrum of parathyroid disorders diagnosed at a tertiary care setting.
    Khan NB; Nawaz MA; Ijaz A; Memon AA; Asif N; Khadim MT; Sawal HA
    J Pak Med Assoc; 2020 Feb; 70(2):243-247. PubMed ID: 32063614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.